Travel restriction put in place to stem the spread of COVID-19 has led to more than 30 overseas GMP inspections postponed, Australian regulator, the Therapeutic Goods Administration (TGA) has revealed.
The dietary supplement industry bodies in both Australia and New Zealand are seeking clarification that the sector is classed as an ‘essential service’, with both countries imposing movement restriction to curb the spread of COVID-19.
This round-up focuses on the vitamin C sales surge in China due to COVID-19, the addition of three 'blue-hat' probiotics formulation to Sirio Pharma and more.
A panel of science researchers has put up a list of key findings on the role of micronutrients in supporting the immune system, which firms can tap on to educate the consumers in light of the coronavirus outbreak.
Eight weeks intake of fermented citrus juice containing lactic acid bacteria has been found to reduce nasal symptoms and increase regulatory T cells (Tregs) in Japanese adults during the peak pollen season.
Sirio Pharma has obtained the ‘blue-hat’ approval for three of its probiotic formulations. The company now has ‘blue-hat’ certificates for four of its probiotic formulations in total.
In this round-up, we shine the spotlight on major brands, including Unilever with its launch of gummy vitamin brand ‘OLLY’ in Singapore, Megmilk Snow Brand’s launch of its first functional yogurt drink and more.
See February's 10 most read stories, including the impact of the novel coronavirus COVID-19 on nutrition businesses, Singapore's lab-grown breast milk innovation and more. Click through the gallery to see them all.
Japanese dairy company, Megmilk Snow Brand has launched the first fermented milk product with a food with function claim (FFC) touted to relieve eye and nose discomfort due to allergies.
Probiotics for managing constipation in children, a Singapore company’s innovation in lab-grown breast milk, and Nestle Health Science China’s two new FSMPs products are some of the most read stories on the social media.
